Cat. No.: X24-09-YM707
E3 ligase ligand-linker conjugate inhibitor, CCK2R ligand-linker conjugate 1, Purity ≥98%
Synonym: 1452145-13-9; AKOS040743140; HY-128941; CS-0102703; (4S)-5-[[(2S)-1-[[(2S)-4-Carboxy-1-[[(2S)-1-[[(1R)-1-carboxy-2-sulfanylethyl]amino]-1,5-dioxo-5-[[(2S,3R,4R,5R)-2,3,4,5,6-pentahydroxyhexyl]amino]pentan-2-yl]amino]-1-oxobutan-2-yl]amino]-1,5-dioxo-5-[[(2S,3R,4R,5R)-2,3,4,5,6-pentahydroxyhexyl]amino]pentan-2-yl]amino]-4-[8-[[3-[[(3R)-1-cyclohexyl-5-(3,3-dimethyl-2-oxobutyl)-4-oxo-2,3-dihydro-1,5-benzodiazepin-3-yl]carbamoylamino]benzoyl]amino]octanoylamino]-5-oxopentanoic acid; E3 ligase ligand-linker conjugate inhibitor
- CAS Number: 1452145-13-9
- Compound CID: 139035090
Product Size
1 mg; 5 mg; 10 mg; 20 mg
Properties
Description
CCK2R ligand-linker conjugate 1 is an effective PROTAC inhibitor, that has the ability to prevent the pathway of E3 ligase ligand-linker conjugation. The molecular weight of the compound is 1607.77, and its molecular formula is C72H110N12O27S.
Molecular Formula
C72H110N12O27S
Impurities
Free from inappropriate visible particulates, foreign matter, discoloration, or other defects.
Identity
Confirmed by NMR/HPLC/MS.
Applications
CCK2R ligand-linker conjugate 1 plays a key role in targeting CCK2 receptors, which are often overexpressed in certain tumors, providing a means for localized drug delivery.
Related Products
- E3 ligase ligand-linker conjugate inhibitor, Pomalidomide-PEG4-Ph-NH2, Purity ≥98%
- E3 ligase ligand-linker conjugate inhibitor, Lenalidomide-C5-NH2, Purity ≥98%
- E3 ligase ligand-linker conjugate inhibitor, (S,R,S)-AHPC-C3-NH2, Purity ≥98%
- E3 ligase ligand-linker conjugate inhibitor, Pomalidomide-C2-amido- (C1-O-C5-O-C1)2-COOH, Purity ≥98%
- E3 ligase ligand-linker conjugate inhibitor, Pomalidomide-C2-NH2, Purity ≥98%
- E3 ligase ligand-linker conjugate inhibitor, Thalidomide-O-amido-PEG2-C2-NH2, Purity ≥98%
